08.05.2013 Views

+ Descargar - Asociación de Investigadores en Relaciones Públicas

+ Descargar - Asociación de Investigadores en Relaciones Públicas

+ Descargar - Asociación de Investigadores en Relaciones Públicas

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

# A6<br />

Laura María Vázquez Viaño: Re<strong>de</strong>s sociales, microblogging y relaciones públicas 2.0<br />

Muchos usuarios aprovechan espacios como Facebook o Twitter con el objetivo <strong>de</strong> apr<strong>en</strong><strong>de</strong>r<br />

sobre su salud, compartir experi<strong>en</strong>cias y socializar con otros paci<strong>en</strong>tes. Esta realidad ha hecho<br />

que la industria farmacéutica española haya com<strong>en</strong>zado a <strong>de</strong>sarrollar estrategias <strong>de</strong> comunicación<br />

2.0, <strong>de</strong> manera que el manejo <strong>de</strong> la disciplina <strong>de</strong> las relaciones públicas online es ya una<br />

t<strong>en</strong><strong>de</strong>ncia incipi<strong>en</strong>te y <strong>de</strong> futuro, especialm<strong>en</strong>te <strong>en</strong> las empresas <strong>de</strong> base internacional, que <strong>en</strong><br />

otros países ya han <strong>de</strong>sarrollado social media policies y gestionan comunida<strong>de</strong>s online <strong>en</strong> las<br />

principales re<strong>de</strong>s.<br />

La investigación estudia la pres<strong>en</strong>cia corporativa <strong>en</strong> re<strong>de</strong>s sociales <strong>de</strong> la industria farmacéutica <strong>en</strong><br />

España y explicita cómo laboratorios como Roche, el Grupo M<strong>en</strong>arini o Pfizer cu<strong>en</strong>tan con<br />

perfiles corporativos 2.0. No obstante, pone <strong>de</strong> relieve cómo las pot<strong>en</strong>cialida<strong>de</strong>s que ofrece la<br />

comunicación online se están empezando a explotar sólo <strong>de</strong> forma tímida y poco bidireccional,<br />

<strong>en</strong> algunos casos con rasgos y cont<strong>en</strong>idos unidireccionales más propios <strong>de</strong>l 1.0 y con pocos<br />

síntomas que <strong>de</strong>not<strong>en</strong> monitorización <strong>de</strong> cont<strong>en</strong>idos.<br />

Palabras clave<br />

E-salud, laboratorio farmacéutico, re<strong>de</strong>s sociales, relaciones públicas 2.0, Facebook, Twitter, medios<br />

sociales.<br />

Abstract<br />

The access to information about health through Web 2.0 or Social Media technologies is already<br />

a mass ph<strong>en</strong>om<strong>en</strong>on. A fifth part of the conversation that takes place online has to do with<br />

cont<strong>en</strong>ts related to health, not only because users access to platforms that offer divulgative<br />

information on this area, but also because, in an emerg<strong>en</strong>t and spontaneous way, they use social<br />

networks and platforms to which they are used to and where they share information in<br />

community, to introduce topics related to health.<br />

Many users take advantage of social networks such as Facebook or Twitter in or<strong>de</strong>r to learn<br />

about their health, share experi<strong>en</strong>ces and socialize with other pati<strong>en</strong>ts. This reality has lead to<br />

the Spanish Pharmaceutical Industry to beginning to <strong>de</strong>velop 2.0 communication strategies.<br />

Therefore, the managing of the online Public Relations discipline is already and emerg<strong>en</strong>t tr<strong>en</strong>d<br />

with much future, especially in companies with international origin that have already <strong>de</strong>veloped<br />

social media policies and manage online communities on main networks in other countries.<br />

This article reviews the corporate pres<strong>en</strong>ce on social networks of the Spanish Pharmaceutical<br />

Industry and highlights how laboratories such us Roche, Grupo M<strong>en</strong>arini and Pfizer do have<br />

their own 2.0 corporate profiles. Nevertheless, it emphasizes how the pot<strong>en</strong>tialities that online<br />

ACTAS ICONO 14 - Nº A6 – pp. 378/394 | 05/2011 | REVISTA DE COMUNICACIÓN Y NUEVAS TECNOLOGÍAS | ISSN:<br />

1697–8293<br />

C/ Salud, 15 5º dcha. 28013 – Madrid | CIF: G - 84075977 | www.icono14.net<br />

379

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!